Released Title Price Sensitive Download Types
2021-01-04 09:16:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/745764e250343935ede96c7044830b1a
    Change of Director's Interest Notice
2021-01-04 16:32:00 Resignation and Appointment of Joint Company Secretary 0 https://app.sharelinktechnologies.com/announcement/asx/d8c5bf92b18678789fa4c3486951db82
    Company Secretary Appointment/Resignation
2021-01-07 09:33:00 Recruitment of head & neck cancer patients completed for ph2 1 https://app.sharelinktechnologies.com/announcement/asx/b282f0aa912f4eba67e545561e46fe27
    Progress Report
2021-01-22 08:54:00 Ulcerative Colitis Phase II Study of GSK2831781 Discontinued 1 https://app.sharelinktechnologies.com/announcement/asx/b49361c2e4d8ba470d13bbe9fa49688d
    Progress Report
2021-01-22 08:57:00 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/134e88f9e15ce676a5042cb5cf1a075d
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2021-01-27 08:59:00 Phase II study for eftilagimod alpha in COVID-19 advances 1 https://app.sharelinktechnologies.com/announcement/asx/664902db7240bb7cba5c66d7b3423171
    Progress Report
2021-02-02 08:22:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/582866b95d1c209f5b4f6d1c7e5f1de3
    Company Presentation
2021-02-23 16:23:00 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/2c9b08f6edafcf14750d2c177dcf3351
    Half Yearly Report
    Half Year Audit Review
    Half Year Directors' Statement
    Half Year Accounts
    Half Year Directors' Report
2021-03-05 08:21:00 Immutep expands Part B of TACTI-002 collaboration trial 1 https://app.sharelinktechnologies.com/announcement/asx/bbb1d7514ab72d46e000dcee74501110
    Progress Report
2021-03-09 16:14:00 Immutep secures second US patent grant for eftilagimod alpha 1 https://app.sharelinktechnologies.com/announcement/asx/41f6b9048f935597ea6e893eff2f0ca2
    Progress Report
2021-03-12 17:02:00 S&P DJI Announces March 2021 Quarterly Rebalance 1 https://app.sharelinktechnologies.com/announcement/asx/c4537e50aec7075a471239bf8c2eda5b
    Standard and Poor's Announcement
2021-03-16 08:17:00 Immutep collaborates with MSD for phase 2b head & neck trial 1 https://app.sharelinktechnologies.com/announcement/asx/7643ce43da10739415e60b72c6637357
    Progress Report
2021-03-18 10:59:00 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/73059327bf6361943da9adde0989e2ca
    Appendix 2A (Application for Quotation of Securities
2021-04-01 08:22:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/385257157ffb8eb99ad6db3df55a79f6
    Change in substantial holding
2021-04-07 08:28:00 Immutep announces European Patent Grant for LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/39a5bf1b616c166cad4fb356fb62458f
    Progress Report
2021-04-08 07:52:00 Immutep achieves Fast Track designation for Efti from US FDA 1 https://app.sharelinktechnologies.com/announcement/asx/a7e3d93fdbadd8d404a04d98ae1a9102
    Progress Report
2021-04-14 09:25:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/eb22db530362edbf05a023e891d31bd6
    Periodic Reports - Other
2021-04-16 17:46:00 Immutep receives A$1,155,055 R&D Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/f58f0089b468a9eeb40e7d741b629853
    Periodic Reports - Other
2021-04-19 09:40:00 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/0c7a329b28494d856af0df7495318cc3
    Commitments Test Entity - Third Quarter Report
    Commitments Test Entity - Third Quarter Activity Report
2021-04-29 07:31:00 TACTI-002 & INSIGHT-004 data to be presented at ASCO 1 https://app.sharelinktechnologies.com/announcement/asx/0fbcf95f9d00a58dbfe5737ae93ebf8d
    Progress Report
2021-05-07 09:49:00 Operational Update 1 https://app.sharelinktechnologies.com/announcement/asx/65107ca1c65ece41c5091bc4c7e527af
    Progress Report
2021-05-13 11:51:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/b11fba3d9bac3dcef04ce7b0c4b7bd81
    Company Presentation
2021-05-14 10:55:00 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/7fb4ed5ef6cb4aab03bcb32ac19d14dc
    Appendix 2A (Application for Quotation of Securities
2021-05-18 08:20:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/8b3f3a2d6233ca833f44e3da4fd9c7c1
    Change in substantial holding
2021-05-20 08:22:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/ff4afb46385008c041a9b8b405c4a5d0
    Change in substantial holding
2021-05-20 13:07:00 TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 0 https://app.sharelinktechnologies.com/announcement/asx/bef8c6c7c58dacf7c66883287f0d7c21
    Progress Report - Other
2021-05-25 08:16:00 Immutep to present at Jefferies Healthcare Conference 0 https://app.sharelinktechnologies.com/announcement/asx/605d69ed40c022f99950f4e6fa278491
    Web Casts
2021-05-26 13:32:00 Immutep granted Chinese patent for its LAG-3 candidate Efti 1 https://app.sharelinktechnologies.com/announcement/asx/5c1429f315dc3790d185d8b2283184f6
    Progress Report
2021-06-01 08:20:00 Immutep enters New Collaboration with Merck KGaA for Efti 1 https://app.sharelinktechnologies.com/announcement/asx/11a993942460c351e34f2d6feb4af49b
    Progress Report
2021-06-02 11:13:00 Immutep granted European patent for its LAG-3 candidate Efti 1 https://app.sharelinktechnologies.com/announcement/asx/e90b85fa55acf843846b49cce6ffcf0f
    Progress Report
2021-06-04 16:14:00 Immutep Reports Positive Final Data from INSIGHT-004 trial 1 https://app.sharelinktechnologies.com/announcement/asx/5637138be503b944b141e6ce009cf008
    Progress Report
2021-06-04 16:17:00 Immutep Reports Positive Data from its TACTI-002 ph 2 trial 1 https://app.sharelinktechnologies.com/announcement/asx/08fcddd4325d30cccf9d542c4c58655f
    Progress Report
    Web Casts
2021-06-04 16:19:00 Immutep presentation for Jefferies Healthcare Conference 0 https://app.sharelinktechnologies.com/announcement/asx/8701ce847fe4795edca20698d8425f9a
    Company Presentation
2021-06-07 16:01:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/b0b347467f1c67446c218755eaf2e112
    Appendix 2A (Application for Quotation of Securities
2021-06-08 07:37:00 Immutep Reveals a New anti-LAG-3 Research Program 1 https://app.sharelinktechnologies.com/announcement/asx/99e8bedefdaa831eb19915a6b3281903
    Progress Report
2021-06-08 16:11:00 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/ecad5c766040f0d922e86cd5af3235a5
    Appendix 2A (Application for Quotation of Securities
2021-06-09 19:21:00 Immutep global webcast slides 1 https://app.sharelinktechnologies.com/announcement/asx/f9b7f433005f5f54b0a5ab7912883edb
    Company Presentation
    Web Casts
2021-06-15 08:17:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/8e5592a98ea23511fcb7184e69ebf3ca
    Change in substantial holding
2021-06-17 08:20:00 Trading Halt 1 https://app.sharelinktechnologies.com/announcement/asx/41936ead4cd5a523509d3eafb78fad91
    Trading Halt
2021-06-21 09:47:00 Immutep secures commitments for A$60 million in a Placement 1 https://app.sharelinktechnologies.com/announcement/asx/a19a324728fe82f5d6036ddefbdb5715
    Placement
    Issued Capital - Other
    Security Purchase Plan
    Trading Halt Lifted
    Company Administration - Other
2021-06-21 09:47:00 Immutep Capital Raising Presentation 1 https://app.sharelinktechnologies.com/announcement/asx/3b8f689fc06fcbb5015f353dfb9806aa
    Company Presentation
2021-06-21 09:48:00 Efti to be evaluated in new triple combination therapy trial 1 https://app.sharelinktechnologies.com/announcement/asx/944de89bb3de4a254cc1f87076ad370c
    Progress Report
2021-06-21 09:48:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/590386b1585cfd8efe4ee8506973d218
    Appendix 3B
2021-06-25 11:39:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/b9e13bbb4fa49f71df87e24bf837af56
    Appendix 2A (Application for Quotation of Securities
2021-06-25 16:04:00 Share Purchase Plan Offer Documents 0 https://app.sharelinktechnologies.com/announcement/asx/df23b9bcb2f8c5b1b0a31e14eff41c7c
    Security Purchase Plan
    Letter to Shareholders
2021-06-25 16:15:00 Notice of Extraordinary General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/9d5d343faa5eb2761f66006ae297d60b
    Notice of Extraordinary General Meeting
    Proxy Form
2021-06-28 08:11:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/219dcbf79a2dc532609951f56fb117c4
    Cleansing Notice
2021-06-30 08:19:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/55f99639fe98995325ac2daeb882cf34
    Ceasing to be a substantial holder
2021-06-30 12:28:00 Change in substantial holding from AEF 0 https://app.sharelinktechnologies.com/announcement/asx/61a5614e8a30da23b962b4b2c91d6e87
    Change in substantial holding
2021-07-05 16:34:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/7872159a956938d7d471562ffb7c171b
    Appendix 3B
2021-07-06 08:58:00 US FDA & IRB approves start of ph2b head & neck cancer trial 1 https://app.sharelinktechnologies.com/announcement/asx/0b9d71777ef1bd3cbd33a70ee3aef1c2
    Progress Report
2021-07-13 09:48:00 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/c1742ebd49f96db1399ca9641226d13e
    Commitments Test Entity - Fourth Quarter Report
    Commitments Test Entity - Fourth Quarter Activity Report
2021-07-15 13:10:00 EGM - Now to be Held as an Online Virtual Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/a36435de51c81afc7d92212918106c77
    Notice of Meeting - Other
    Web Casts
2021-07-21 09:00:00 Completion of Share Purchase Plan 1 https://app.sharelinktechnologies.com/announcement/asx/d55a0c77b19929af14b4239f6b75b11a
    Issued Capital - Other
    Security Purchase Plan
2021-07-23 08:25:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/d1fc971a2866361ec311f5aa157aa650
    Change in substantial holding
2021-07-23 08:25:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/0a1ccb4455027c2ec08a701650d9af65
    Appendix 2A (Application for Quotation of Securities
2021-07-26 11:56:00 2021 EGM Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/f10312319d80acbce69c18ecfd259d44
    Company Presentation
2021-07-26 12:04:00 Chairman's EGM Address 0 https://app.sharelinktechnologies.com/announcement/asx/d560eaa15d64f0d5f07dfcf637e686b5
    Chairman's Address to Shareholders
2021-07-26 18:37:00 Results of EGM 0 https://app.sharelinktechnologies.com/announcement/asx/b928c3771ba7ce5d2ae41f37c1e7f38b
    Results of Meeting
2021-07-27 08:15:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/da000531257c421e2801e91309b5eee8
    Appendix 3B
2021-07-27 08:19:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/225ff93f0931bddc2021042e7ec46e6d
    Change in substantial holding
2021-07-29 08:22:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/bc65adefe6e522d5efe382b9a0b7ec57
    Appendix 2A (Application for Quotation of Securities
2021-07-30 09:24:00 Completion of Placement - Tranche 2 1 https://app.sharelinktechnologies.com/announcement/asx/d14e7c81279f79065a955a473fd062ec
    Placement
2021-07-30 10:03:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/926f48d93f7fda9edcad84be555e7ca6
    Cleansing Notice
2021-08-03 08:21:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/ca6dc040baa03420b9619e75b58d547b
    Change in substantial holding
2021-08-03 19:18:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/4bc0db212051d228aeb70df0808bc605
    Becoming a substantial holder
2021-08-05 08:18:00 INSIGHT-003 investigator-initiated trial - 1st patient dosed 1 https://app.sharelinktechnologies.com/announcement/asx/6cead79bcb3c82fde88d5f347d415107
    Progress Report
2021-08-27 08:04:00 Chinese patent granted for anti-LAG-3 antibody LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/ed73b96655191eb3ebc84098357a844f
    Progress Report
2021-08-30 19:08:00 Appendix 4E & 2021 Full Year Statutory Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/86dbf512036b38e34ff51d1b390db197
    Annual Report
    Top 20 shareholders
    Preliminary Final Report
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
    Corporate Governance
2021-08-31 08:46:00 Immutep's partner, EOC Pharma, expands efti trial pipeline 1 https://app.sharelinktechnologies.com/announcement/asx/1311bd70fafe93f8a246910e17c235ee
    Progress Report
2021-09-01 10:07:00 Recruitment of patients completed for Part B of TACTI-002 1 https://app.sharelinktechnologies.com/announcement/asx/c67d3418fb751a5fa7577505cb8c91b1
    Progress Report
2021-09-21 18:38:00 Immutep to present final AIPAC Overall Survival data at SITC 0 https://app.sharelinktechnologies.com/announcement/asx/5156847da7a212d1a9de72f125c39e29
    Progress Report
    Company Administration - Other
2021-09-27 18:37:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/b6154f501fe21cfdd17b7fc80d19143b
    Company Presentation
2021-09-28 12:09:00 Immutep to Present at Healthcare Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/774a4d56eb2f56ccfeaa1e37ef5e464d
    Web Casts
2021-09-29 08:47:00 Immutep Receives A$3.4 million R&D French Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/e99859ed8d6f1d1986dbeb05bfe5f9c9
    Progress Report
    Company Administration - Other
2021-10-01 11:55:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/6cfea084902d5c66a2ea4dbc313eb6e4
    Appendix 2A (Application for Quotation of Securities
2021-10-01 16:16:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/991ca2dd442f81448e391b132ec3e36d
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-10-04 08:24:00 Immutep to present Phase II TACTI-002 data at SITC 2021 0 https://app.sharelinktechnologies.com/announcement/asx/3c075f3eb1be075178cff9a3ad69405e
    Progress Report
2021-10-04 09:25:00 Change of Director's Interest Notice - Mr Meyers 0 https://app.sharelinktechnologies.com/announcement/asx/cfbcb7d8a4fd5eb695e33b1671e68707
    Change of Director's Interest Notice
2021-10-04 09:27:00 Change of Director's Interest Notice - Mr Chamberlain 0 https://app.sharelinktechnologies.com/announcement/asx/3369f3c41c53303c5f96f4ecbc17596e
    Change of Director's Interest Notice
2021-10-07 08:46:00 Ceasing to be a substantial holder from AEF 0 https://app.sharelinktechnologies.com/announcement/asx/0ce4ad84fd3333f1204b5785fe2bb2e0
    Ceasing to be a substantial holder
2021-10-12 19:03:00 2021 AGM & Key Dates 0 https://app.sharelinktechnologies.com/announcement/asx/c83c36b48c4350fdee205cb15fa3ca66
    Notice of Meeting - Other
2021-10-26 09:05:00 Annual Report filed on Form 20-F with SEC 0 https://app.sharelinktechnologies.com/announcement/asx/891c87830897ce4d5c969a183540a428
    Annual Report
2021-10-26 09:14:00 Annual Report to shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/06713e913038d3cf46e27aa7bc95a99e
    Annual Report
    Top 20 shareholders
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2021-10-26 09:39:00 Appendix 4G 0 https://app.sharelinktechnologies.com/announcement/asx/763775cf42cedaa11b603cf08c108d9f
    Takeover - Appendix 4G
2021-10-26 10:35:00 Notice of Annual General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/6f48101f02d6674a56f47cb8804d76e3
    Notice of Annual General Meeting
    Proxy Form
2021-10-28 08:30:00 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/855fce1e934f3c0385997495db732dae
    Commitments Test Entity - First Quarter Report
    Commitments Test Entity - First Quarter Activity Report
2021-10-29 08:19:00 Immutep receives EMA scientific advice for Phase 3 in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/ca244b6daefe038f50d8411b5d6e33a8
    Progress Report
    Company Administration - Other
2021-11-02 10:57:00 Immutep granted Chinese Patent for eftilagimod alpha 1 https://app.sharelinktechnologies.com/announcement/asx/d6654fa7dbb3580ce94afb08c97e4429
    Progress Report
2021-11-08 16:18:00 JobKeeper Payment Notice 0 https://app.sharelinktechnologies.com/announcement/asx/b8aad393fc0a75dcf0b503fc3b4cba5f
    Periodic Reports - Other
2021-11-10 08:24:00 Final Phase IIb AIPAC clinical trial results for Efti in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/b53092617dbfa6d862ec000ef13df73f
    Progress Report
2021-11-10 08:24:00 Immutep announces publication of SITC 2021 abstracts 1 https://app.sharelinktechnologies.com/announcement/asx/684d9f6ae38f620630aedc945a0b08aa
    Progress Report
    Company Administration - Other
2021-11-15 08:37:00 Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors 1 https://app.sharelinktechnologies.com/announcement/asx/3090f8a5cac202c64488a0890c4d65a6
    Progress Report
2021-11-15 08:37:00 Immutep announces publication of SITC 2021 posters 1 https://app.sharelinktechnologies.com/announcement/asx/e251b3b86c5dd8b811c47b44abddccba
    Progress Report
    Web Casts
2021-11-16 18:19:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/96153bffcddaa46a61baaab412e8f7b9
    Change in substantial holding
2021-11-17 07:30:00 Immutep Global Webcast Slides to Discuss Clinical Results 1 https://app.sharelinktechnologies.com/announcement/asx/197511d1eae1c986a4f919e533259060
    Company Presentation
2021-11-17 08:17:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/f13ec698c2dd728de6589a1c1e35c25c
    Change in substantial holding
2021-11-19 08:30:00 Phase II TACTI-002 trial recruitment successfully completed 1 https://app.sharelinktechnologies.com/announcement/asx/fc72d114de30e049da50e3054ad4c3a0
    Progress Report
2021-11-26 08:16:00 Immutep AGM 2021 - Chairman's Address 0 https://app.sharelinktechnologies.com/announcement/asx/212adc0869702b1df7c9cddea9d7e6ed
    Chairman's Address to Shareholders
2021-11-26 08:17:00 Immutep AGM 2021 - CEO's Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/d7cd08eb52aa9ca1a906cd8b18ed14da
    Company Presentation
    Chairman's Address to Shareholders
2021-11-26 12:35:00 Results of Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/e8e6b723bd8237bb629ba987ae25b92b
    Results of Meeting
2021-11-30 14:15:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/c98734468564b37ba1b1157cbe6a3648
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-11-30 14:26:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/59bd1164d7bcd45f25fae73f8484e803
    Appendix 3B
2021-12-01 17:27:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/3f6b7296b0e86c88dea0a20b6509a32d
    Appendix 2A (Application for Quotation of Securities
2021-12-01 17:44:00 Change of Director's Interest Notice - Mr Voigt 0 https://app.sharelinktechnologies.com/announcement/asx/f825777804a92c2bd8dbf272d2c22a82
    Change of Director's Interest Notice
2021-12-01 17:46:00 Change of Director's Interest Notice - Dr. Howard 0 https://app.sharelinktechnologies.com/announcement/asx/f1815d607d71d2288f30094edbfcfc9b
    Change of Director's Interest Notice
2021-12-02 08:22:00 Good safety reported from 1st five patients in INSIGHT-003 1 https://app.sharelinktechnologies.com/announcement/asx/278faf2976f68418b87ab5936e881556
    Progress Report
2021-12-02 19:41:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/7405ee816f92aab7ced121588aab5f6b
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2021-12-06 08:22:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/d2865d515a3aa7c6994a6ae07a86737f
    Change in substantial holding
2021-12-14 16:10:00 Amended Constitution 0 https://app.sharelinktechnologies.com/announcement/asx/d322b7f2f1078e2cdb5ca0586aac9d2c
    Constitution
2021-12-14 16:14:00 Change of Registered Office Address 0 https://app.sharelinktechnologies.com/announcement/asx/1aff9c0d4f9a45dedabde63328e3013f
    Details of Company Address
    Details of Registered office address
2021-12-16 08:20:00 Immutep Advances IMP761 Manufacturing 1 https://app.sharelinktechnologies.com/announcement/asx/82fcbe1c20c94827f4d4e8d93dcb7cdc
    Progress Report
Powered by Share Link